- Country: Spain
- Summary: Supply of Medications with Active Substance Eculizumab for the Treatment of Nocturnal Paroxysmal Hemoglobinuria and Uremic Hemolytic Syndrome to Health Centers Dependent on ...
- EST Ref No: 114192309
- Deadline: 04 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 5192880
- Notice Type: Tender
- Document Ref. No.: 74510-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of medicines with active ingredient Eculizumab for the treatment of nocturnal paroxysmal hemoglobinuria and uremic hemolytic syndrome to health centers dependent on ...
supply of medicines with active ingredient Eculizumab for the treatment of hemoglobinuria - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Medications with Active Substance Eculizumab for the Treatment of Nocturnal Paroxysmal Hemoglobinuria and Uremic Hemolytic Syndrome to Health Centers Dependent on ... - Spain Tender
The MURCIAN HEALTH SERVICE, a Government sector organization in Spain, has announced a new tender for Supply of Medications with Active Substance Eculizumab for the Treatment of Nocturnal Paroxysmal Hemoglobinuria and Uremic Hemolytic Syndrome to Health Centers Dependent on .... This tender is published on SpainTenders under EST Ref No: 114192309 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-04.
The estimated tender value is EUR 5192880, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
